Fundraising Fox

Abalos Therapeutics

2 known investors

Find your way into Abalos Therapeutics

Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.

BiotechHealthtech

Investors · 2

Ventura BioMed InvestorsMunich · $1.1M – $5.5M
Boehringer Ingelheim Venture FundreportedIngelheim am Rhein · $16.2M

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries A ExtensionOct 2021 · 2 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Abalos Therapeutics Raises €32.5M in Series A Extensionfinsmes.com · Oct 2021Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Millionbusinesswire.com · Oct 2021Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer - BioSpacebiospace.com · Oct 2019Abalos Therapeutics Raises €12M in Series A Funding - FinSMEsfinsmes.com · Oct 2019

Frequently asked questions

What does Abalos Therapeutics do?
Abalos Therapeutics develops immunotherapy treatments using arenavirus-based approaches for cancer. The company serves cancer patients and is located in Germany, operating in the biotech sector.
Who are Abalos Therapeutics's investors?
Abalos Therapeutics's investors include Ventura BioMed Investors, Boehringer Ingelheim Venture Fund.